02926nam a2200445 i 45000010008000000030008000080050017000160060019000330070007000520080041000590200033001000350017001330390012001500400036001620500023001980900025002211000026002462450136002722640066004082640011004743000023004853360021005083370023005293380032005524900044005845000029006285040051006575051213007085060060019215960007019816500042019886500035020306500024020656500034020898300045021238560110021689490014022789260105022927580083023976786272FlBoTFG20150115163112.0m|||||o||d||||||||cr||||150115r20152015fluad   ob    001 0 eng d  a9781482256604 (e-book : PDF)  aocn900602660  aexclude  aFlBoTFGbengerdacFlBoTFGdAEU 4aR853.C55bC43 2015  aInternet AccessbAEU1 aChang, Mark,eauthor.10aAdaptive design theory and implementation using SAS and R /cMark Chang, AMAG Pharmaceuticals, Inc., Lexington, Massachusetts, USA. 1aBoca Raton, FL :bCRC Press :bTaylor & Francis Group,c2015. 4cÂ©2015  a1 online resource.  atext2rdacontent  acomputer2rdamedia  aonline resource2rdacarrier1 aChapman & Hall/CRC biostatistics series  a"A Chapman & Hall book."  aIncludes bibliographical references and index.0 aIntroduction -- Classical design -- Theory of hypothesis-based adaptive design -- Method with direct combination of p-values -- Method with inverse-normal p-values -- Adaptive noninferiority design with paired binary data -- Adaptive design with incomplete paired data -- K-stage adaptive designs -- Conditional error function method and conditional power -- Recursive adaptive design -- Unblinded sample-size reestimation design -- Blinded and semi-blinded sample-size reestimation design -- Adaptive design with coprimary endpoints -- Multiple-endpoint adaptive design -- Pick-the-winners design -- The add-arm design for unimodal response -- Biomarker-enrichment design -- Biomarker-informed adaptive design -- Survival modeling and adaptive treatment switching -- Response-adaptive allocation design -- Introductory Bayesian approach in clinical trial -- Adaptive dose-escalation trial -- Bayesian design for efficacy-toxicity trade-off and drug combination -- Bayesian approach to biosimilarity trial -- Adaptive multiregional trial design -- SAS and R modules for group sequential design -- Data analysis of adaptive trial -- Planning, execution, analysis, and reporting -- Debates in adaptive designs.  aAccess restricted to authorized users and institutions.  a44 0aClinical trialsxStatistical methods. 0aAdaptive sampling (Statistics) 0aSAS (Computer file) 0aR (Computer program language) 0aChapman & Hall/CRC biostatistics series.403University of Alberta Accessuhttp://marc.crcnetbase.com/isbn/9781482256604z(Unlimited Concurrent Users)  hUAINzCRC  aInternet AccesswLCc1i6786272-1001lINTERNETmUAINTERNETrYsYtE-RESOURCEu1/20/2015xE-BOOKzCRC01ahttp://id.loc.gov/authorities/names/n2006054152bhttp://viaf.org/viaf/43727698